| (+)-alpha-tocopherol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [arsenite results in increased expression of TXN1 protein] | CTD | PMID:21344382 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:732441 | 6480464 | epigallocatechin gallate results in increased expression of TXN mRNA | CTD | PMID:20706672 |
| (-)-selegiline | multiple interactions | ISO | RGD:732441 | 6480464 | Dinitrochlorobenzene inhibits the reaction [Selegiline results in increased expression of TXN]; more ... | CTD | PMID:16099847 |
| (-)-selegiline | increases expression | ISO | RGD:732442 | 6480464 | Selegiline results in increased expression of TXN protein | CTD | PMID:16099847 |
| (-)-selegiline | affects response to substance | ISO | RGD:732442 | 6480464 | TXN protein affects the susceptibility to Selegiline | CTD | PMID:16099847 |
| (-)-selegiline | increases expression | ISO | RGD:732441 | 6480464 | Selegiline results in increased expression of TXN protein | CTD | PMID:16099847 |
| (-)-selegiline | affects response to substance | ISO | RGD:732441 | 6480464 | TXN protein affects the susceptibility to Selegiline | CTD | PMID:16099847 |
| 1,4-dithiothreitol | multiple interactions | ISO | RGD:732441 | 6480464 | Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] | CTD | PMID:18922898 |
| 1-chloro-2,4-dinitrobenzene | multiple interactions | ISO | RGD:732441 | 6480464 | Dinitrochlorobenzene inhibits the reaction [Selegiline results in increased expression of TXN]; more ... | CTD | PMID:16099847 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:732442 | 6480464 | Dinitrochlorobenzene results in increased expression of TXN1 mRNA | CTD | PMID:19647056 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of TXN mRNA | CTD | PMID:17522070 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of TXN mRNA | CTD | PMID:16174780 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of TXN1 mRNA | CTD | PMID:17108234 PMID:19400957 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:732442 | 6480464 | Ethinyl Estradiol results in increased expression of TXN1 mRNA | CTD | PMID:19400957 PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of TXN1 mRNA | CTD | PMID:19400957 PMID:17108234 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:732442 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TXN1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:732442 | 6480464 | Ethinyl Estradiol affects the expression of TXN1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:732442 | 6480464 | Ethinyl Estradiol results in increased expression of TXN1 mRNA | CTD | PMID:17942748 PMID:19400957 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:732441 | 6480464 | TXN protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR mRNA] | CTD | PMID:11462148 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732442 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TXN1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732442 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TXN1 mRNA | CTD | PMID:16214954 PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:732442 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TXN1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732442 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TXN1 mRNA | CTD | PMID:17942748 PMID:16214954 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:11462148 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of TXN1 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of TXN1 mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of TXN1 protein | CTD | PMID:17178593 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:732442 | 6480464 | Glucosamine results in decreased expression of TXN1 protein | CTD | PMID:17178593 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:732442 | 6480464 | Oxazolone results in increased expression of TXN1 mRNA | CTD | PMID:19647056 |
| 4-hydroxynon-2-enal | decreases activity | ISO | RGD:732441 | 6480464 | 4-hydroxy-2-nonenal results in decreased activity of TXN protein | CTD | PMID:17982132 |
| 4-hydroxynon-2-enal | affects metabolic processing | ISO | RGD:732441 | 6480464 | 4-hydroxy-2-nonenal affects the metabolism of TXN protein | CTD | PMID:17982132 |
| 4-methylaminophenol | increases expression | ISO | RGD:732441 | 6480464 | metol results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of TXN1 mRNA | CTD | PMID:19483382 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in decreased expression of TXN1 protein] | CTD | PMID:20453393 |
| 8-bromo-3',5'-cyclic GMP | multiple interactions | EXP | | 6480464 | 8-bromocyclic GMP inhibits the reaction [Glucose results in decreased expression of TXN1 protein] | CTD | PMID:20453393 |
| acrolein | increases oxidation | ISO | RGD:732441 | 6480464 | Acrolein results in increased oxidation of TXN protein | CTD | PMID:19135121 PMID:18023956 |
| acrolein | increases oxidation | ISO | RGD:732441 | 6480464 | Acrolein results in increased oxidation of TXN protein | CTD | PMID:18023956 PMID:19135121 |
| acrolein | decreases activity | ISO | RGD:732441 | 6480464 | Acrolein results in decreased activity of TXN protein | CTD | PMID:17982132 PMID:15388247 |
| acrolein | increases oxidation | ISO | RGD:732441 | 6480464 | Acrolein results in increased oxidation of TXN protein | CTD | PMID:18023956 |
| acrolein | decreases activity | ISO | RGD:732441 | 6480464 | Acrolein results in decreased activity of TXN protein | CTD | PMID:15388247 PMID:17982132 |
| acrolein | affects metabolic processing | ISO | RGD:732441 | 6480464 | Acrolein affects the metabolism of TXN protein | CTD | PMID:17982132 |
| acrolein | multiple interactions | ISO | RGD:732441 | 6480464 | Acetylcysteine inhibits the reaction [Acrolein results in increased oxidation of TXN protein] | CTD | PMID:18023956 |
| acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of TXN1 mRNA | CTD | PMID:15749267 |
| aflatoxin B1 | affects expression | ISO | RGD:732441 | 6480464 | Aflatoxin B1 affects the expression of TXN protein | CTD | PMID:20106945 |
| aldehydo-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of TXN1 protein | CTD | PMID:17178593 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:732442 | 6480464 | Glucosamine results in decreased expression of TXN1 protein | CTD | PMID:17178593 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:732441 | 6480464 | Tretinoin results in decreased expression of TXN mRNA | CTD | PMID:21934132 |
| amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of TXN1 mRNA | CTD | PMID:19483382 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of TXN1 mRNA | CTD | PMID:16483693 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [arsenite results in increased expression of TXN1 protein] | CTD | PMID:21344382 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of TXN1 protein | CTD | PMID:21344382 |
| atenolol | increases expression | ISO | RGD:732441 | 6480464 | Atenolol results in increased expression of TXN mRNA | CTD | PMID:19915711 |
| ATP | increases expression | ISO | RGD:732441 | 6480464 | Adenosine Triphosphate results in increased expression of TXN protein | CTD | PMID:22129738 |
| benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of TXN1 mRNA | CTD | PMID:19483382 |
| benzene | multiple interactions | ISO | RGD:732442 | 6480464 | [Benzene co-treated with TXN protein] results in decreased expression of AHR mRNA; more ... | CTD | PMID:17157166 |
| benzene | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to Benzene | CTD | PMID:17157166 |
| benzo[a]pyrene | increases expression | ISO | RGD:732442 | 6480464 | Benzo(a)pyrene results in increased expression of TXN1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TXN1 protein | CTD | PMID:16456883 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene promotes the reaction [sodium arsenite results in increased expression of TXN1 protein]; more ... | CTD | PMID:16456883 |
| benzo[a]pyrene | increases expression | ISO | RGD:732441 | 6480464 | Benzo(a)pyrene results in increased expression of TXN mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | increases expression | ISO | RGD:732442 | 6480464 | Benzo(a)pyrene results in increased expression of TXN1 mRNA | CTD | PMID:21715664 PMID:22228805 |
| benzo[d]isothiazol-3-one | increases expression | ISO | RGD:732441 | 6480464 | 1,2-benzisothiazoline-3-one results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| benzoic acid | increases expression | ISO | RGD:732441 | 6480464 | Benzoic Acid results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| beta-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of TXN1 protein | CTD | PMID:17178593 |
| beta-D-glucosamine | decreases expression | ISO | RGD:732442 | 6480464 | Glucosamine results in decreased expression of TXN1 protein | CTD | PMID:17178593 |
| bisphenol A | decreases expression | ISO | RGD:732441 | 6480464 | bisphenol A results in decreased expression of TXN mRNA | CTD | PMID:20678512 |
| bromobenzene | affects binding | EXP | | 6480464 | bromobenzene metabolite binds to TXN1 protein | CTD | PMID:17305373 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of TXN1 mRNA | CTD | PMID:19167457 |
| cadmium atom | increases expression | ISO | RGD:732441 | 6480464 | Cadmium results in increased expression of TXN protein | CTD | PMID:16440303 |
| cadmium dichloride | increases expression | ISO | RGD:732441 | 6480464 | Cadmium Chloride results in increased expression of TXN protein | CTD | PMID:16440303 |
| cadmium dichloride | multiple interactions | ISO | RGD:732441 | 6480464 | Cytochalasin D inhibits the reaction [Cadmium Chloride affects the localization of TXN protein] | CTD | PMID:22961094 |
| cadmium dichloride | affects localization | ISO | RGD:732442 | 6480464 | Cadmium Chloride affects the localization of TXN1 protein | CTD | PMID:22961094 |
| cadmium dichloride | affects localization | ISO | RGD:732441 | 6480464 | Cadmium Chloride affects the localization of TXN protein | CTD | PMID:18261755 PMID:22961094 |
| cadmium dichloride | increases expression | ISO | RGD:732442 | 6480464 | Cadmium Chloride results in increased expression of TXN1 mRNA | CTD | PMID:22677785 |
| cadmium dichloride | increases oxidation | ISO | RGD:732441 | 6480464 | Cadmium Chloride results in increased oxidation of TXN protein | CTD | PMID:16337887 |
| cadmium dichloride | affects localization | ISO | RGD:732441 | 6480464 | Cadmium Chloride affects the localization of TXN protein | CTD | PMID:18261755 |
| cadmium dichloride | multiple interactions | ISO | RGD:732442 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TXN1 mRNA | CTD | PMID:19840844 |
| carvedilol | increases expression | EXP | | 6480464 | carvedilol results in increased expression of TXN1 protein | CTD | PMID:20403466 |
| chloroform | increases expression | EXP | | 6480464 | Chloroform results in increased expression of TXN mRNA | CTD | PMID:17522070 |
| chlorogenic acid | increases expression | ISO | RGD:732441 | 6480464 | Chlorogenic Acid results in increased expression of TXN mRNA | CTD | PMID:20706672 |
| chromium(6+) | increases oxidation | ISO | RGD:732441 | 6480464 | chromium hexavalent ion results in increased oxidation of TXN protein | CTD | PMID:21237240 |
| cisplatin | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to Cisplatin | CTD | PMID:10754530 |
| cisplatin | multiple interactions | ISO | RGD:732441 | 6480464 | Cisplatin promotes the reaction [TXNRD1 protein binds to TXN1 protein] | CTD | PMID:20851179 |
| clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of TXN1 mRNA | CTD | PMID:19483382 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of TXN mRNA | CTD | PMID:17522070 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TXN1 mRNA | CTD | PMID:17602206 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of TXN1 mRNA | CTD | PMID:17602206 |
| copper(2+) sulfate | increases expression | ISO | RGD:732441 | 6480464 | Copper Sulfate results in increased expression of TXN mRNA | CTD | PMID:19549813 |
| copper(II) chloride | increases expression | ISO | RGD:732441 | 6480464 | cupric chloride results in increased expression of TXN mRNA | CTD | PMID:17211630 |
| cyclosporin A | increases expression | ISO | RGD:732441 | 6480464 | Cyclosporine results in increased expression of TXN mRNA | CTD | PMID:20106945 |
| cytochalasin D | multiple interactions | ISO | RGD:732441 | 6480464 | Cytochalasin D inhibits the reaction [Cadmium Chloride affects the localization of TXN protein] | CTD | PMID:22961094 |
| D-glucose | decreases expression | ISO | RGD:732442 | 6480464 | Glucose results in decreased expression of TXN1 protein | CTD | PMID:17178593 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of TXN1 protein | CTD | PMID:17178593 PMID:20453393 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of TXN1 protein | CTD | PMID:20453393 PMID:17178593 |
| D-glucose | multiple interactions | EXP | | 6480464 | 8-bromocyclic GMP inhibits the reaction [Glucose results in decreased expression of TXN1 protein]; more ... | CTD | PMID:20453393 |
| diarsenic trioxide | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20707922 |
| diarsenic trioxide | increases oxidation | ISO | RGD:732441 | 6480464 | arsenic trioxide results in increased oxidation of TXN protein | CTD | PMID:17640917 |
| diarsenic trioxide | increases response to substance | ISO | RGD:732441 | 6480464 | TXN1 results in increased susceptibility to arsenic trioxide | CTD | PMID:18922898 |
| diarsenic trioxide | increases oxidation | ISO | RGD:732441 | 6480464 | arsenic trioxide results in increased oxidation of TXN1 protein | CTD | PMID:18922898 |
| diarsenic trioxide | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20707922 PMID:22590507 |
| diazoxide | decreases expression | ISO | RGD:732442 | 6480464 | Isoproterenol results in decreased expression of TXN1 mRNA | CTD | PMID:21335049 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of TXN1 mRNA | CTD | PMID:21266533 |
| diclofenac | increases expression | ISO | RGD:732441 | 6480464 | Diclofenac results in increased expression of TXN mRNA | CTD | PMID:19022234 |
| diethyl maleate | decreases activity | ISO | RGD:732441 | 6480464 | diethyl maleate results in decreased activity of TXN protein | CTD | PMID:15388247 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of TXN1 mRNA | CTD | PMID:16122865 |
| dioxygen | multiple interactions | ISO | RGD:732441 | 6480464 | TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK8 protein]; more ... | CTD | PMID:20812253 |
| dioxygen | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to Oxygen | CTD | PMID:20812253 |
| diphenylcyclopropenone | increases expression | ISO | RGD:732441 | 6480464 | diphenylcyclopropenone results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| dipyridamole | multiple interactions | EXP | | 6480464 | KT 5823 inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in decreased expression of TXN1 protein]]; more ... | CTD | PMID:20453393 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TXN1 protein | CTD | PMID:12221060 |
| elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of TXN1 mRNA | CTD | PMID:15792362 |
| elemental selenium | affects expression | EXP | | 6480464 | Selenium affects the expression of TXN1 mRNA | CTD | PMID:19351701 |
| fluorescein 5-isothiocyanate | increases expression | ISO | RGD:732441 | 6480464 | Fluorescein-5-isothiocyanate results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| formaldehyde | increases expression | ISO | RGD:732441 | 6480464 | Formaldehyde results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| fumonisin B1 | increases expression | ISO | RGD:732442 | 6480464 | fumonisin B1 results in increased expression of TXN1 mRNA | CTD | PMID:16221962 |
| furan | affects binding | EXP | | 6480464 | furan binds to TXN1 protein | CTD | PMID:22240984 |
| genistein | decreases expression | ISO | RGD:732441 | 6480464 | Genistein results in decreased expression of TXN mRNA | CTD | PMID:20706672 |
| glucose | decreases expression | ISO | RGD:732442 | 6480464 | Glucose results in decreased expression of TXN1 protein | CTD | PMID:17178593 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of TXN1 protein | CTD | PMID:17178593 PMID:20453393 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of TXN1 protein | CTD | PMID:20453393 PMID:17178593 |
| glucose | multiple interactions | EXP | | 6480464 | 8-bromocyclic GMP inhibits the reaction [Glucose results in decreased expression of TXN1 protein]; more ... | CTD | PMID:20453393 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:10754530 PMID:16024017 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:16024017 PMID:10754530 |
| hydroquinone | increases expression | ISO | RGD:732441 | 6480464 | hydroquinone results in increased expression of TXN mRNA | CTD | PMID:15452088 |
| hydroxycitronellal | increases expression | ISO | RGD:732441 | 6480464 | hydroxycitronellal results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| indomethacin | multiple interactions | ISO | RGD:732441 | 6480464 | TXN protein inhibits the reaction [Indomethacin results in decreased expression of AKT1 protein modified form]; more ... | CTD | PMID:17654042 |
| indomethacin | multiple interactions | EXP | | 6480464 | TXN protein inhibits the reaction [Indomethacin results in decreased expression of BIRC5 protein] | CTD | PMID:17654042 |
| isoprenaline | decreases expression | ISO | RGD:732442 | 6480464 | Isoproterenol results in decreased expression of TXN1 mRNA | CTD | PMID:21335049 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [arsenite results in increased expression of TXN1 protein] | CTD | PMID:21344382 |
| L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of TXN1 mRNA | CTD | PMID:19483382 |
| linalool | increases expression | ISO | RGD:732441 | 6480464 | linalool results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| LY294002 | multiple interactions | ISO | RGD:732441 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TXN protein results in decreased susceptibility to Oxygen] | CTD | PMID:20812253 |
| maneb | increases expression | ISO | RGD:732441 | 6480464 | [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of TXN1 mRNA | CTD | PMID:21402726 |
| mercury atom | affects binding | ISO | RGD:732441 | 6480464 | Mercury binds to TXN protein | CTD | PMID:18321861 |
| mercury dichloride | multiple interactions | ISO | RGD:732441 | 6480464 | Mercuric Chloride results in decreased activity of and affects the metabolism of TXN protein | CTD | PMID:18321861 |
| mercury dichloride | increases oxidation | ISO | RGD:732441 | 6480464 | Mercuric Chloride results in increased oxidation of TXN protein | CTD | PMID:16337887 |
| mercury dichloride | decreases expression | ISO | RGD:732441 | 6480464 | Mercuric Chloride results in decreased expression of TXN protein | CTD | PMID:17959236 |
| mercury dichloride | multiple interactions | ISO | RGD:732441 | 6480464 | Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in decreased expression of TXN protein]; more ... | CTD | PMID:17959236 |
| mercury(0) | affects binding | ISO | RGD:732441 | 6480464 | Mercury binds to TXN protein | CTD | PMID:18321861 |
| methyl non-2-ynoate | increases expression | ISO | RGD:732441 | 6480464 | 2-nonynoic acid methyl ester results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:732441 | 6480464 | Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein] | CTD | PMID:17959236 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:732441 | 6480464 | Acetylcysteine inhibits the reaction [NCX 4040 results in increased oxidation of TXN1 protein] | CTD | PMID:18922898 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:732441 | 6480464 | Acetylcysteine inhibits the reaction [Acrolein results in increased oxidation of TXN protein] | CTD | PMID:18023956 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:732442 | 6480464 | Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] | CTD | PMID:16449798 |
| N-acetyl-L-cysteine | decreases expression | ISO | RGD:732441 | 6480464 | Acetylcysteine results in decreased expression of TXN protein | CTD | PMID:17959236 |
| N-methyl-4-phenylpyridinium | affects response to substance | ISO | RGD:732442 | 6480464 | TXN protein affects the susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:16099847 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of and results in increased oxidation of TXN1 protein | CTD | PMID:20600802 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:732442 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TXN1 mRNA; more ... | CTD | PMID:19840844 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TXN1 mRNA | CTD | PMID:17602206 |
| NADP zwitterion | multiple interactions | EXP | | 6480464 | [TXN1 protein co-treated with INS1 protein] inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides] | CTD | PMID:20457604 |
| NADP(+) | multiple interactions | EXP | | 6480464 | [TXN1 protein co-treated with INS1 protein] inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides] | CTD | PMID:20457604 |
| naloxone | increases expression | EXP | | 6480464 | Naloxone results in increased expression of TXN mRNA | CTD | PMID:17522070 |
| nitrogen dioxide | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Nitrogen Dioxide] results in increased expression of TXN1 mRNA | CTD | PMID:10986008 |
| okadaic acid | decreases expression | ISO | RGD:732441 | 6480464 | Okadaic Acid results in decreased expression of TXN protein | CTD | PMID:19397276 |
| okadaic acid | multiple interactions | ISO | RGD:732442 | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TXN1 mRNA | CTD | PMID:19840844 |
| omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of TXN1 mRNA | CTD | PMID:19483382 |
| ouabain | affects expression | ISO | RGD:732441 | 6480464 | Ouabain affects the expression of TXN protein | CTD | PMID:17268060 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Nitrogen Dioxide] results in increased expression of TXN1 mRNA | CTD | PMID:10986008 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of TXN mRNA | CTD | PMID:17522070 |
| paracetamol | decreases expression | ISO | RGD:732441 | 6480464 | Acetaminophen results in decreased expression of TXN mRNA | CTD | PMID:22230336 |
| paracetamol | affects expression | ISO | RGD:732442 | 6480464 | Acetaminophen affects the expression of TXN1 mRNA | CTD | PMID:17562736 |
| paraquat | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to Paraquat | CTD | PMID:10754530 PMID:16024017 |
| paraquat | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to Paraquat | CTD | PMID:10754530 more ... |
| paraquat | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to Paraquat | CTD | PMID:16024017 PMID:10754530 |
| paraquat | increases expression | ISO | RGD:732442 | 6480464 | Paraquat results in increased expression of TXN1 mRNA | CTD | PMID:17215068 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of TXN1 mRNA | CTD | PMID:16328009 |
| paraquat | increases oxidation | ISO | RGD:732441 | 6480464 | Paraquat results in increased oxidation of TXN1 protein | CTD | PMID:21402726 |
| perfluorooctanoic acid | affects expression | ISO | RGD:732442 | 6480464 | perfluorooctanoic acid affects the expression of TXN1 mRNA | CTD | PMID:18281256 |
| perillyl aldehyde | multiple interactions | ISO | RGD:732441 | 6480464 | perillaldehyde promotes the reaction [NFE2L2 protein binds to TXN enhancer]; more ... | CTD | PMID:19123792 |
| perillyl aldehyde | increases expression | ISO | RGD:732441 | 6480464 | perillaldehyde results in increased expression of TXN protein; more ... | CTD | PMID:19123792 |
| phenethyl isothiocyanate | increases expression | ISO | RGD:732441 | 6480464 | phenethyl isothiocyanate results in increased expression of TXN mRNA | CTD | PMID:20442190 |
| phenethyl isothiocyanate | affects binding | ISO | RGD:732441 | 6480464 | TXN protein binds to phenethyl isothiocyanate | CTD | PMID:21838287 |
| phenethyl isothiocyanate | increases metabolic processing | ISO | RGD:732441 | 6480464 | phenethyl isothiocyanate results in increased metabolism of TXN protein | CTD | PMID:21838287 |
| phenethyl isothiocyanate | increases expression | EXP | | 6480464 | phenethyl isothiocyanate results in increased expression of TXN1 mRNA | CTD | PMID:17616710 |
| phlorizin | decreases expression | ISO | RGD:732442 | 6480464 | Phlorhizin results in decreased expression of TXN mRNA | CTD | PMID:22538082 |
| phlorizin | increases expression | ISO | RGD:732442 | 6480464 | Phlorhizin results in increased expression of TXN mRNA | CTD | PMID:22538082 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:732442 | 6480464 | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TXN1 mRNA | CTD | PMID:19840844 |
| pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of TXN1 mRNA | CTD | PMID:19483382 |
| propiconazole | increases expression | ISO | RGD:732442 | 6480464 | propiconazole results in increased expression of TXN1 mRNA | CTD | PMID:21278054 |
| propiconazole | increases expression | ISO | RGD:732442 | 6480464 | propiconazole results in increased expression of TXN1 mRNA | CTD | PMID:21278054 PMID:22334560 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of TXN protein | CTD | PMID:16198371 |
| resveratrol | increases expression | ISO | RGD:732441 | 6480464 | resveratrol results in increased expression of TXN mRNA | CTD | PMID:20706672 |
| resveratrol | increases expression | ISO | RGD:732441 | 6480464 | resveratrol results in increased expression of TXN protein | CTD | PMID:16198371 |
| ribavirin | decreases expression | ISO | RGD:732441 | 6480464 | Ribavirin results in decreased expression of TXN protein | CTD | PMID:16198661 |
| rotenone | multiple interactions | ISO | RGD:732442 | 6480464 | Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] | CTD | PMID:16449798 |
| salicylic acid | increases expression | ISO | RGD:732441 | 6480464 | Salicylic Acid results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of TXN1 mRNA | CTD | PMID:15792362 |
| selenium atom | affects expression | EXP | | 6480464 | Selenium affects the expression of TXN1 mRNA | CTD | PMID:19351701 |
| sildenafil | increases expression | EXP | | 6480464 | sildenafil results in increased expression of TXN1 | CTD | PMID:18373738 |
| silver atom | increases expression | ISO | RGD:732441 | 6480464 | Silver results in increased expression of TXN1 mRNA | CTD | PMID:22079246 |
| silver atom | increases expression | ISO | RGD:732441 | 6480464 | Silver results in increased expression of TXN1 mRNA | CTD | PMID:22036727 |
| silver(0) | increases expression | ISO | RGD:732441 | 6480464 | Silver results in increased expression of TXN1 mRNA | CTD | PMID:22079246 |
| silver(0) | increases expression | ISO | RGD:732441 | 6480464 | Silver results in increased expression of TXN1 mRNA | CTD | PMID:22036727 |
| sodium dodecyl sulfate | increases expression | ISO | RGD:732441 | 6480464 | Sodium Dodecyl Sulfate results in increased expression of TXN mRNA | CTD | PMID:20491607 |
| streptozocin | multiple interactions | ISO | RGD:732442 | 6480464 | TXN protein inhibits the reaction [Streptozocin results in increased secretion of ALB protein] | CTD | PMID:17360766 |
| succimer | multiple interactions | ISO | RGD:732442 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TXN1 mRNA | CTD | PMID:21641980 |
| sulforaphane | increases expression | ISO | RGD:732441 | 6480464 | sulforafan results in increased expression of TXN mRNA | CTD | PMID:20442190 |
| sulforaphane | increases expression | ISO | RGD:732441 | 6480464 | sulforafan results in increased expression of TXN mRNA | CTD | PMID:19123792 PMID:20442190 |
| sulindac | increases response to substance | ISO | RGD:732441 | 6480464 | TXN1 results in increased susceptibility to Sulindac analog | CTD | PMID:18922898 |
| superoxide | multiple interactions | EXP | | 6480464 | [TXN1 protein co-treated with INS1 protein] inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides] | CTD | PMID:20457604 |
| tacrolimus hydrate | decreases expression | EXP | | 6480464 | Tacrolimus results in decreased expression of TXN mRNA | CTD | PMID:17085464 |
| tamoxifen | affects expression | ISO | RGD:732442 | 6480464 | Tamoxifen affects the expression of TXN1 mRNA | CTD | PMID:17555576 |
| tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of TXN1 mRNA | CTD | PMID:19400957 |
| tamoxifen | increases expression | ISO | RGD:732442 | 6480464 | Tamoxifen results in increased expression of TXN1 mRNA | CTD | PMID:19400957 |
| TCEP | multiple interactions | ISO | RGD:732441 | 6480464 | tris(2-carboxyethyl)phosphine inhibits the reaction [sodium chromate(VI) results in increased oxidation of TXN protein] | CTD | PMID:19135121 |
| tert-butyl hydroperoxide | decreases response to substance | ISO | RGD:732441 | 6480464 | TXN protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:10754530 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of TXN mRNA | CTD | PMID:17522070 |
| tetracycline | increases expression | EXP | | 6480464 | Tetracycline results in increased expression of TXN mRNA | CTD | PMID:17522070 |
| thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of TXN1 mRNA | CTD | PMID:19483382 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:732442 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of TXN1 mRNA | CTD | PMID:19647056 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of TXN protein | CTD | PMID:16198371 |
| trans-resveratrol | increases expression | ISO | RGD:732441 | 6480464 | resveratrol results in increased expression of TXN mRNA | CTD | PMID:20706672 |
| trans-resveratrol | increases expression | ISO | RGD:732441 | 6480464 | resveratrol results in increased expression of TXN protein | CTD | PMID:16198371 |
| trimellitic anhydride | increases expression | ISO | RGD:732442 | 6480464 | trimellitic anhydride results in increased expression of TXN1 mRNA | CTD | PMID:19042947 |
| troglitazone | increases expression | ISO | RGD:732441 | 6480464 | troglitazone results in increased expression of TXN mRNA | CTD | PMID:19022234 |
| valproic acid | decreases expression | ISO | RGD:732442 | 6480464 | Valproic Acid results in decreased expression of TXN1 mRNA | CTD | PMID:20546886 |